Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD
PHASE3
This is a Phase III randomized, double-blind, parallel group, multi-center,...
A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma
PHASE3
To demonstrate that CHF 1535 via NEXT DPI (beclomethasone dipropionate + fo...
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
PHASE4
This study will evaluate the effect of triple ICS/LAMA/LABA therapy with a ...
Status
Recruiting
Location
Medical Center Hermes Ruse LTD 12 Chavdar Voyvoda St.
Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)
PHASE3
Primary Objective
• To demonstrate the superiority of CHF 5993 pressurised...